Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.5863
+0.0436 (8.03%)
At close: Dec 19, 2025, 4:00 PM EST
0.6200
+0.0337 (5.75%)
Pre-market: Dec 22, 2025, 7:12 AM EST
Elutia Market Cap
Elutia has a market cap or net worth of $25.04 million as of December 22, 2025. Its market cap has decreased by -84.75% in one year.
Market Cap
25.04M
Enterprise Value
49.45M
1-Year Change
-84.75%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $25.04M, a decrease of -85.60%. That is a compound annual growth rate of -31.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 25.04M | -80.63% |
| Dec 31, 2024 | 129.26M | 157.97% |
| Dec 29, 2023 | 50.11M | -26.88% |
| Dec 30, 2022 | 68.53M | -19.77% |
| Dec 31, 2021 | 85.42M | -38.72% |
| Dec 31, 2020 | 139.38M | -19.82% |
| Oct 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |